chrisvoncsefalvay/vaers-outcomes huggingface dataset:
For a few weeks after vaccine #2 I had fatigue and joint pain. It subsided a little bit. Then the last week of April 2021 it became more intense and has been ever since. I had joint pain and fatigue that did not go away with rest. Prior to the COVID vaccine, I had never had problems with joint pain before. It started in my left hip and has moved to my knees and ankles. I was taking 1-4 ibuprofen at a time for pain. Sometimes it would help and sometimes it wouldn't. Finally I visited my PCP on 7/8/2021 when the joint pain and fatigue was so great that I was having trouble working in my job (retail merchandiser) and performing my household duties. I could still do what I needed to do, I was just slower and in discomfort. My PCP ordered some autoimmune bloodwork, a hip xray (to check for osteoarthritis), and referred me to a rheumatologist. I cannot get in to see a rheumatologist until October 2021. We have insurance  and there are only 3 rheumatologists within 50 miles of my address (and I live in the city, state area). She said ANA bloodwork was on the high end which could point to rheumatoid arthritis. I know these joint pain/fatigue symptoms may not be related to the COVID vaccine, but wanted to report them just in case. It sure is a coincidence that the joint pain (which I never had prior to a COVID vaccine) started within weeks of the vaccine.
Itchy rash around injection site and on legs, both "real red" (None on arms, face or anywhere else) Took Benadryl to help itching. She saw Dr. No additional treatment needed.
Pt was given COVID19 Pfizer-BioNTech instead of COVID19 Pfizer-BioNTech Bivalent.  Vials look very similar in size, color. The wrong vial was pulled in order to draw up and administer.  Pt tolerated injection well and was monitored for 15 minutes post injection.  No adverse effects noted. Pt tolerated well.
I had mostly flu like symptoms. The day before testing positive, I began to feel sick with a fever. I had chills through that night and was extremely exhausted. My fever was about low 100 (maybe 104-107). I did at home test Tuesday, and it was negative but Wednesday night I tested positive. For the next 3 days, I was feeling very feverish and tired, but I could not break my fever. After the 3 days, my fever broke but I had cold symptoms until the following week: cough, congestion and all sinus cold symptoms. The coughing lasted for a few weeks, starting as a congested cough and turned into a dry cough.
Symptoms include fever of 102, extreme exhaustion, body aches  continued and ongoing already 5 days after the injection.  Have still not improved.
his prior tinnitus has got worse after the vaccination; has mild headaches and he never has headaches; fatigue; left pain arm at the injection site; has left side sharped chest pain mostly when he exhales, daily; not been feeling well/not feel like himself,; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily) and FATIGUE (fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chest pain and Tinnitus since an unknown date.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ILLNESS (not been feeling well/not feel like himself,). On 23-Feb-2021, the patient experienced CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily). On an unknown date, the patient experienced HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Chest pain, at a dose of UNK UNK, 5 times/wk. At the time of the report, ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided Treatment information included Tylenol around 5 pills since symptoms started
nearly died; got GBS from the shot, nearly died; This case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced near death experience (serious criteria GSK medically significant and life threatening) and guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the near death experience and guillain barre syndrome were unknown.   It was unknown if the reporter considered the near death experience to be related to Shingles vaccine. The reporter considered the guillain barre syndrome to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 25-SEP-2022 Reporter's Comment: This case was reported by a patient's wife via interactive digital media. The patient got GBS (Guillain Barre syndrome) from the Shingles shot and nearly died. Additional Supportive Information: The follow up would not possible as no contact details were available.
This case was reported by a consumer via call center representative and described the occurrence of periocular swelling in a 71-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (received 10 years ago). On 5th October 2018, the patient received the 1st dose of SHINGRIX. In October 2018, 10 days after receiving SHINGRIX, the patient experienced periocular swelling, dry skin, eye pruritus, burning in eyes, flaking skin and swelling of eyelid. The patient was treated with ophthalmologicals (Eye Drops) and erythromycin cream. On an unknown date, the outcome of the periocular swelling, dry skin, eye pruritus, burning in eyes, flaking skin and swelling of eyelid were not recovered/not resolved. It was unknown if the reporter considered the periocular swelling, dry skin, eye pruritus, burning in eyes, flaking skin and swelling of eyelid to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the right arm. The patient experienced itching and burning around and in her eyes. The patient also experienced swelling of the eyelids and the skin around her eyes. The patient also reported that the skin around her eyelids had become dry and was flaking off. The patient went to see her doctor and was prescribed eye drops and erythromycin 5% antibiotic cream. The patient stated that neither of these medications have helped. The patient consented to follow up.
patient developed burning inside arm after injection and subsequently developed a burn to the area of the left deltoid with subsequent desquamation of skin.
patient reports he "passed out" and slowly rolled his car into the car in front of him at drive thru vaccine event. Vasovagal event resolved within minutes and pt improved
Redness around injection site. Redness under armpit. Swollen lymph node. Pain as area of injection. Slight itching.
Myalgia, Arthralgia, Fever, fever; body aches; chills; joint pain; back pain (around/in kidneys) Narrative:  OTC Ibuprofen as needed  Other Relevant History:
it made me very sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a 50-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included rash (had rash in eye) and headache (had absolutely horrid nonstop headaches). Concurrent medical conditions included scar.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were reported as follows: The patient self-reported this case. The patient was 49 years old and had asked for vaccine before and was told not old enough.  The patient went to emergency room with rash in eye and absolutely horrid nonstop headaches.  The patient had scars on his/her face. The patient got vaccine following year and was very sick 2 days. For tolerance to 2nd dose Shingles vaccine, refer case US2021AMR183340.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183340:Same reporter
Approximately 29 hours (5. PM Tuesday) after I received the 1 st Moderna vaccine, I developed a redness and swelling at the injection site.  My arm became painful all around the shoulder and halfway down my upper arm.  I was unable to lift my arm without major discomfort.  I applied ice packs to the site every hour and took ibuprofen every 8 hours through Thursday morning.  My arm was better and although I still had some discomfort I was able to move my arm more freely.  The redness was gone and the swelling was down.
pt devel red rash on 6NOV96-also fever;17NOV96 bleeding gums & bruises on arms-was seen by MD adm to hosp x 2 days;dec platelet count;dx ITP;
Patient had rapid heart beat that occurred on and off of approximately 10-15 minute intervals over the course of 40 minutes. His face also felt warm at the temple area. His blood pressure was elevated when taken by EMT services but pulse was normal. EMT was called and he was given the option to go to the hospital which he did as precaution.
Presented like a stroke approximately 22 hours later - slouched, leaning sideways, breathing, but unresponsive.  Called EMTs who transported her to ER where tests showed slight fever and minor dehydration
MMRV  Proquad given to patient above age range.  Patient did not have any adverse reaction at time in clinic.
HARD TIME SLEEPING; MUSCLE SPASMS; COVID-19; INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED; This spontaneous report received from a consumer concerned a 7 decade old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received ibrutinib (tablet, oral, batch number was not reported) 420 mg, 1 time every 1 day, therapy dates were not reported for an unspecified indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported, and dose was not reported, administered on MAR-2021 for covid-19 vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the patient experienced inappropriate schedule of vaccine administered. On SEP-2021, the patient experienced covid-19. On an unspecified date, the patient experienced hard time sleeping, and muscle spasms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and dose of ibrutinib was not changed. The patient was recovering from covid-19, and muscle spasms, and the outcome of hard time sleeping and inappropriate schedule of vaccine administered was not reported. This report was non-serious.
Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 031L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.            Treatment: given Hot bath.   This case was linked to MOD-2021-386875, MOD-2021-386893 (Patient Link).
Rash on right forearm with swelling and tenderness. No erythema or lymphangitis. Right deltoid area normal.
localized reaction to varicella vaccine - site swelled to approximately 7 x 10 cm with warmth adn slight pain
lips went numb; hard to breathe; upper respiratory system was clogged; sinuses was clogged; tired; she went to bed a couple of hours before she usually does; This is a spontaneous report received from a contactable consumer (patient) via medical information team. A 60-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCIN, Solution for injection, Lot number: ER8727, Expiration date: unknown) via an unspecified route of administration in left arm on 07Apr2021 at 11:30 (at the age of 60-year-old) as single dose for COVID-19 immunization. Medical history of the patient included arthritis (hip arthritis), allergies (week prior to vaccine) and shellfish reaction; all from an unknown date. Concomitant medications included Loratadine (MANUFACTURER UNKNOWN) [24-hour tablet, sold over the counter], acetylsalicylic acid [ASPIRIN 500 mg] taken for arthritis in her hip. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6207, expiration: unknown) via an unspecified route of administration in left shoulder, upper arm on 17Mar2021 (at the age of 60-year-old) as single dose for COVID-19 immunization. On 07Apr2021, right after second dose of vaccination patient was tired and went to bed a couple of hours before she usually does. On 08Apr2021, almost 24 hours after second dose, while patient was doing a low impact exercise routine at home, she noticed it was harder to breathe and her upper respiratory system was clogged, sinuses was clogged, and her lips went numb which was similar to her shellfish reaction she has had in the past. Patient asked if her symptoms are normal and if it was safe for her to go back to work as she works at a deli and asked if she was contagious to her coworkers. Patient had allergies the week prior, so she was unsure if her symptoms are from her allergies or the vaccine. Patient took benadryl and Robitussin with guaifenesin to help with the symptoms. Outcome of all events was resolving.  No follow-up attempts are needed; No further information is expected
Information has been received from a nurse concerning a 41 year old female with tuberculin test positive (02/15/2005) who on 02/15/2005 was vaccinated subcutaneously with a 0.5ml dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant therapy included tuberculin purified protein derivative and diphtheria toxoid/tetanus toxoid.  5 to 7 days post vaccination, on approximately 02/20/2005, the patient developed fever, rash, swollen glands and conjunctivitis.  On approximately 02/25/2005, the patient had bumps on the back of her neck, lumphadenopathy.  On approximately 02/26/2005, the patient had a rash on her belly, arms and thighs.  On 03/04/2005, the patient was seen in the physicians office with a fine reticular rash which was fading, lymphadenopathy which was better, pink eye which was continued and fever was gone.  The patient was treated with sulfacetamide sodium eye drops.  The patient had also taken ibuprofen at home, but had discontinued use of ibuprofen as of 03/04/2005.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 5/27/2005.  Initial and follow up information has been received from a licensed visiting nurse and physician concerning a 41 year old female with tuberculin test positive (15-Feb-2005) and no other pre-existing allergies, birth defects or medical conditions reported.  On 15-FEB-2005 the patient was vaccinated subcutaneously in the right arm with a 0.5ml dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant therapy included tuberculin purified protein derivative and diphtheria toxoid/tetanus toxoid.  Five to seven days post-vaccination, on approximately 20-FEB-2005, the patient developed fever, rash, swollen glands and conjunctivitis.  On approximately 25-FEB-2005, the patient had bumps on the back of her neck, lumphadenopathy.  On approximately 26-FEB-2005, the patient had a rash on her belly, arms and thighs.  On 04-MAR-2005, the patient was seen in the physician's office with a fine reticular rash which was fading, lymphadenopathy which was better, pink eye which was continued and fever was gone.  The patient was treated with SULAMYD eye drops.  The patient had also taken ADVIL at home, but had discontinued use of ibuprofen as of 04-MAR-2005.  As of 15-MAR-2005, the patient had recovered from the events.  No further information is available.
Patient developed pain in right shoulder, arm and down to hand described as a deep ache the evening after her vaccination which continued more than 48 hours after vaccination.
about 2hrs after shot got really tired, lasted  about 2hrs. Next day Sat. in afternoon broke in rash on chest, shoulders, and back. On left arm about 3 inches below injection had a round spot (red) about the size of a tennis ball. Next day Sun. rash got better. Next day Mon. rash got worse. Next day Tues. got better, almost gone by Tues. night. Red spot on arm almost gone. Wed. morning a little rash on chest right below neck.
Basically the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Basically the flu) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe).   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced INFLUENZA (Basically the flu). At the time of the report, INFLUENZA (Basically the flu) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No relevant concomitant medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment medication reported.   The reporter's causality for the event(s) of basically the flu with HUMIRA(ADALIMUMAB) was a reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
About 5 minutes after the shot, patient's mom said that she didn't feel good.  Patient was dizzy, sweaty, nauseas and really hot.   The arm that got the injection was also really hot.  I had the patient lay down, and gave her an ice pack for her neck/arm.  After a few minutes patient said that she felt better.  I had her lay down for about 5 minutes.  She then sat up and said she was much better.  Wasn't dizzy or nauseous anymore.  Arm felt better too.  I had the patient sit and wait in total 30 minutes.  Mom wanted to leave sooner but I asked if she wait so that we could make sure she was ok.  THey waited 30minutes and left .  patient was fine.
Chills, shivering, constant dry mouth, headache.  Above symptoms lasted for 14 hours after onset.
Cloudy head; Headache; Fever of 99.7; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8729) via an unspecified route of administration in the right arm on 13Apr2021 at 17:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, panic disorder and depression. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), levocetirizine (MANUFACTURER UNKNOWN), rabeprazole (MANUFACTURER UNKNOWN) and calcium lactate (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6207) via an unspecified route of administration in the right arm on 23Mar2021 at 14:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation and also received codeine (MANUFACTURER UNKNOWN) and azithromycin (ZPAKS) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021, the patient experienced persistent headache, fever of 99.7 and intense fatigue. On 15Apr2021, patient left with fatigue and cloudy head. On 14Apr2021, the patient body temperature was measured and the result was 99.7 (unspecified units). The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of headache, fever of 99.7, fatigue and cloudy head was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient's shoulder has been sore ever since receiving the vaccination 2 months ago. The soreness is the same as when she 1st got it and has not abated.
pt became nauseous; 3 days later started vomiting 1x day-3 days;then started cont vomiting;tests;IV's-eventually adm to hosp for tests, tx;released still suffering from nausea & vomiting and headaches\ probably due to tension headache;cont now;60 day follow-up dated 9/22/00 states the pt still suffers from gastroparesis, neuropathy of stomach which prevents digestion of food. She has not had a menses since 7/99 and is not having an increase in reflux. The absence of her period is due to her dramatic weight loss from her inability to eat.
Information has been received from a physician concerning a male who on unspecified date, was vaccinated with the first 0.65 ml dose of ZOSTAVAX (Merck) (lot # not reported) at a pharmacy. Other suspect therapy included a chemotherapy (unspecified). Several weeks later the patient developed shingles. The physician said that he was not surprised that the event happened because it was given before the patient started on chemotherapy. The physician believed that ZOSTAVAX (Merck) decreased the severity of the disease. And the physician did not consider the event to be an adverse experience. At the time of reporting, the out come of shingles was unknown. The patient sought unspecified medical attention. No further information is available.
Developed hives to extremities and tightness to throat.  Treated at Emergency Room.